Tango Therapeutics, Inc. (TNGX)
NASDAQ·Healthcare·Biotechnology
$24.63
-6.53%
Mkt Cap $3.23B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $500.40K | — | — | -$0.31 | -$0.29 | +6.45% | — | — |
| Q4 2025 Nov 4, 2025 | $556.00K | $53.81M | +9578.24% | $0.01 | $0.13 | +1200.00% | — | — |
| Q3 2025 Aug 5, 2025 | $6.41M | $3.18M | -50.34% | -$0.35 | -$0.35 | +0.00% | — | — |
| Q2 2025 May 12, 2025 | $6.36M | $5.39M | -15.21% | -$0.34 | -$0.36 | -5.88% | — | — |
| Q1 2025 Feb 27, 2025 | $8.02M | $4.12M | -48.64% | -$0.32 | -$0.35 | -9.37% | — | — |
| Q4 2024 Nov 6, 2024 | $8.02M | $11.61M | +44.76% | -$0.34 | -$0.27 | +20.59% | — | — |
| Q3 2024 Aug 7, 2024 | $7.42M | $19.88M | +167.86% | -$0.34 | -$0.24 | +29.41% | — | — |
| Q2 2024 May 8, 2024 | $6.67M | $6.47M | -2.98% | -$0.31 | -$0.35 | -12.90% | — | — |
| Q1 2024 Mar 18, 2024 | $8.24M | $5.43M | -34.12% | -$0.28 | -$0.32 | -14.29% | — | — |
| Q4 2023 Nov 8, 2023 | $8.62M | $10.73M | +24.50% | -$0.34 | -$0.23 | +32.35% | — | — |
| Q3 2023 Aug 7, 2023 | $7.58M | $14.60M | +92.59% | -$0.35 | -$0.23 | +34.29% | — | — |
| Q2 2023 May 9, 2023 | $6.71M | $5.77M | -14.07% | -$0.36 | -$0.32 | +11.11% | — | — |
| Q1 2023 Mar 27, 2023 | $6.44M | $6.41M | -0.45% | -$0.36 | -$0.33 | +8.33% | — | — |
| Q4 2022 Nov 10, 2022 | $5.64M | $6.92M | +22.64% | -$0.32 | -$0.33 | -3.13% | — | — |
| Q3 2022 Aug 10, 2022 | $5.66M | $5.77M | +1.97% | -$0.33 | -$0.28 | +15.15% | — | — |
| Q2 2022 May 11, 2022 | $5.83M | $5.76M | -1.31% | -$0.28 | -$0.29 | -3.57% | — | — |
| Q1 2022 Mar 28, 2022 | $6.57M | $5.72M | -13.06% | -$0.28 | -$0.25 | +10.71% | — | — |
| Q4 2021 Nov 9, 2021 | $6.26M | $6.79M | +8.33% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q3 2021 Aug 6, 2021 | — | $18.15M | — | — | -$0.05 | — | — | — |
| Q3 2021 Jul 17, 2021 | — | $6.39M | — | — | -$0.14 | — | — | — |